Focus on Neurology and Psychiatry

Innovations in MS: Mechanisms of Disease Progression and Immune Reconstitution

01.30.2018 - By ReachMDPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

Host: Matt Birnholz, MD

Guest: Andrew Chan, MD

Guest: Tobias Derfuss, MD

Guest: Gavin Giovannoni, MBBCh, PhD

Rapid advances in the management of multiple sclerosis reflects an evolving landscape whose emergent treatment philosophies are focused on improving both short- and long-term patient outcomes. This interview reviews different management strategies as well as the importance of personalized treatment, and what they mean for you and your patients. Join Professor Andrew Chan, Professor Tobias Derfuss, and Dr. Gavin Giovannoni as they review management strategies and practical considerations for each and every patient affected by multiple sclerosis. This is the first of two discussions recorded at McCann Complete Medical’s special meeting on multiple sclerosis held in Baveno, Italy. Click here to view the second discussion titled The New MS Treatment Landscape: Personalized Management Strategies. Disclaimer: Some products discussed in this activity have not received regulatory approval by the US FDA for the treatment of patients with Multiple Sclerosis. The FDA has stated that “good medical practice and the best interests of the patient require that physicians use legally available drugs, biologics and devices according to their best knowledge and judgement.”

More episodes from Focus on Neurology and Psychiatry